Compounds with a Benzo[a]carbazole structure and their uses
The present invention concerns the development of new derivatives with apoptosis-modulating action by inhibition of the MDM2/p53 complex.
Synthetic analogues of xanthohumol
The present invention relates to new synthetic analogs of Xanthohumol (XN), a naturally occurring prenylated chalcone found in the female inflorescence of the hop plant (Humulus lupulus L. - Cannabaceae). Xanthohumol is a flavonoid known for its multiple properties
Synthetic analogues of 3-iodothyronamine (T1AM) and uses thereof
The invention aims to the development of new synthetic analogs of 3-iodothyronamine (T1AM), an exponent of a class of endogenous molecules derived from thyroid hormones. The possible main therapeutic uses are: treatment of obesity and dyslipidemia,neuro-psychiatric and behavioral disorders,neurodegenerative diseases.
Melanocortin agents for use in the therapeutic treatment of melanoma, tumors of the gastrointestinal tract, and thyroid carcinoma
The present invention belongs to the field of therapeutic treatments of cancer diseases, particularly solid tumors such as melanoma, cancers of the gastrointestinal tract and thyroid carcinoma. The use of a melanocortin 4 receptor antagonist offers a possible new target therapy in the treatment of cancer diseases, counteracting the possibility of recurrence.
Sensorized device for the analysis of a fluid by means of acoustic waves
The invention is a portable device for the detection of traumatic brain injuries (TBI) biomarkers from rapid blood analysis.
Health-Met
The invention, called Health-Met, is a technology designed for any person who is required to wear a helmet, both in the workplace and in the recreational environment.